Peginesatide Recall and Fatal Anaphylaxis: A Perspective

Jeffrey Berns comments on the recall of peginesatide, the recently approved erythropoiesis-stimulating agent, in light of deaths from a severe allergic reaction in dialysis patients.

Source: Medscape Family Medicine Podcast - February 28, 2013 Category: Primary Care Authors: Medscape Source Type: podcasts